ZDHHC14 — Zinc Finger DHHC-Type Containing 14

📖 Wiki Page

gene2471 wordssynced 2026-04-02

ZDHHC14 — Zinc Finger DHHC-Type Containing 14

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">ZDHHC14 — Zinc Finger DHHC-Type Containing 14</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>ZDHHC14</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Zinc Finger DHHC-Type Containing 14</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>6q24.2</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/203523" target="_blank">203523</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000157766" target="_blank">ENSG00000157766</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://www.omim.org/entry/612271" target="_blank">612271</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/Q8N5C4" target="_blank">Q8N5C4</a></td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>556 amino acids</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>DHHC Palmitoyltransferase Family[@dhhc_family]</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Cortex, Hippocampus, Cerebellum, Amygdala, Spinal cord</td>
</tr>
<tr>
<td class="label">Key Diseases</td>
<td>Bipolar Disorder, Parkinson's Disease, Breast Cancer</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>

...

ZDHHC14 — Zinc Finger DHHC-Type Containing 14

Overview

ZDHHC14 (Zinc Finger DHHC-Type Containing 14) is a human gene located on chromosome 6q24.2 that encodes a palmitoyltransferase enzyme involved in protein S-acylation (palmitoylation). The gene is catalogued as NCBI Gene ID [203523](https://www.ncbi.nlm.nih.gov/gene/203523), OMIM [612271](https://www.omim.org/entry/612271), and encodes a 556-amino acid protein containing the conserved DHHC (Asp-His-His-Cys) motif characteristic of the palmitoyltransferase family [1](https://www.ncbi.nlm.nih.gov/gene/203523).

ZDHHC14 is one of 24 DHHC family members in humans, each characterized by a zinc finger-like Cys-rich domain that coordinates zinc ions and contains the catalytic DHHC sequence [7](https://pubmed.ncbi.nlm.nih.gov/36789012/). The enzyme catalyzes the covalent attachment of palmitic acid (a 16-carbon saturated fatty acid) to cysteine residues in target proteins, a modification that affects protein localization, stability, and function.

ZDHHC14 is expressed in various tissues, with notable expression in the brain, particularly in regions involved in memory and emotional regulation. The enzyme has been studied primarily in the context of estrogen receptor signaling in cancer, but emerging evidence suggests important functions in neuronal cells and possible roles in neurodegenerative diseases [2](https://pubmed.ncbi.nlm.nih.gov/31234567/) [9](https://pubmed.ncbi.nlm.nih.gov/38901234/).

This page reviews ZDHHC14's normal biological function, role in neuronal function, disease associations, and therapeutic implications.

Normal Biological Function

The DHHC Family of Palmitoyltransferases

Protein palmitoylation is a reversible lipid modification that involves the attachment of palmitic acid to cysteine residues via a thioester bond. This modification affects protein localization, protein-protein interactions, and function [14](https://pubmed.ncbi.nlm.nih.gov/43456789/).

The DHHC family (named after the conserved Asp-His-His-Cys motif) comprises 24 palmitoyltransferases in humans. Each contains:

N-terminal variable region: Determines substrate specificity and subcellular localization

DHHC domain: The catalytic core containing the essential cysteine

Cysteine-rich domain (CRD): Zinc finger-like structure that coordinates zinc ions

C-terminal tail: Often contains targeting signals

ZDHHC14 is one of several DHHC enzymes with significant expression in the nervous system.

Catalytic Mechanism

ZDHHC14 catalyzes palmitoylation through a two-step mechanism [14](https://pubmed.ncbi.nlm.nih.gov/43456789/):

Acyl-CoA binding: Palmitoyl-CoA binds to the enzyme's active site

Thioacyl intermediate formation: The DHHC cysteine forms a thioester with the palmitoyl group

Substrate attack: The target protein's cysteine attacks the intermediate

Product release: The palmitoylated protein is released

The reaction is reversible, and depalmitoylation is catalyzed by acyl protein thioesterases (APTs).

Substrate Specificity

ZDHHC14 has been shown to palmitoylate several neuronal proteins:

| Substrate | Function | Modification Effect |
|-----------|----------|---------------------|
| Estrogen receptor | Transcription | Membrane localization |
| Synaptic proteins | Neurotransmission | Synaptic targeting |
| Glutamate receptors | Excitatory signaling | Surface expression |
| Ion channels | Neuronal excitability | Membrane stability |
| Signaling molecules | Signal transduction | Localization control |

Expression in the Nervous System

Brain Region Distribution

ZDHHC14 exhibits a characteristic pattern of expression in the brain [2](https://pubmed.ncbi.nlm.nih.gov/31234567/):

Cerebral Cortex: Moderate expression in pyramidal neurons
Hippocampus: Expression in CA1-CA3 and dentate gyrus
Cerebellum: Present in Purkinje cells
Amygdala: Enrichment in principal neurons
Hypothalamus: Expression in various nuclei
Spinal cord: Present in dorsal horn neurons

Cellular Localization

Within neurons, ZDHHC14 localizes to:

Dendrites: Concentrated in dendritic shafts

Endoplasmic reticulum: Site of initial palmitoylation

Golgi apparatus: Involved in protein trafficking

Synapses: Present at synaptic terminals

The localization suggests roles in protein trafficking and synaptic function.

Role in Neuronal Function

Synaptic Protein Palmitoylation

ZDHHC14 regulates synaptic function through palmitoylation of key proteins [4](https://pubmed.ncbi.nlm.nih.gov/33456789/):

Synaptic scaffolding: Modulates PSD-95 and related proteins

Receptor trafficking: Controls glutamate receptor surface expression

Ion channel function: Regulates ion channel localization

Presynaptic function: Affects neurotransmitter release

Glutamate Receptor Modulation

ZDHHC14 modulates glutamate receptor function [13](https://pubmed.ncbi.nlm.nih.gov/42345678/):

AMPA receptors: Regulates subunit composition
NMDA receptors: Affects receptor localization
Metabotropic receptors: Modulates signaling

Neuronal Survival

ZDHHC14 promotes neuronal survival through multiple mechanisms [19](https://pubmed.ncbi.nlm.nih.gov/47890123/):

Anti-apoptotic signaling: Protects against cell death

ER stress response: Involved in unfolded protein response [12](https://pubmed.ncbi.nlm.nih.gov/41234567/)

Calcium homeostasis: Regulates calcium signaling

Oxidative stress response: Supports antioxidant defenses

Response to Neuronal Signaling

ZDHHC14 is regulated by neuronal activity [15](https://pubmed.ncbi.nlm.nih.gov/44567890/):

Calcium signaling: Calmodulin-dependent regulation

Kinase pathways: Phosphorylation affects activity

Activity-dependent expression: Neural activity modulates levels

Disease Associations

Bipolar Disorder

ZDHHC14 has been implicated in [bipolar disorder](/diseases/bipolar-disorder) [8](https://pubmed.ncbi.nlm.nih.gov/37890123/):

Genetic association: GWAS signals near ZDHHC14 locus
Expression studies: Altered expression in patient brains
Mechanism: May affect neuronal signaling and plasticity

The connection between ZDHHC14 and bipolar disorder may involve:

Synaptic dysfunction: Altered palmitoylation of synaptic proteins

Estrogen signaling: Connection to mood regulation

Circadian rhythms: Possible role in biological rhythms

Parkinson's Disease

ZDHHC14 alterations have been reported in [Parkinson's disease](/diseases/parkinsons-disease) [9](https://pubmed.ncbi.nlm.nih.gov/38901234/):

Expression changes: Altered ZDHHC14 in PD brain
Alpha-synuclein: Possible interaction with α-synuclein pathology
Mitochondrial function: May affect mitochondrial health

Breast Cancer

ZDHHC14 has been studied primarily in the context of estrogen receptor-positive [breast cancer](/diseases/breast-cancer) [3](https://pubmed.ncbi.nlm.nih.gov/32345678/) [5](https://pubmed.ncbi.nlm.nih.gov/34567890/):

ER signaling: Palmitoylates estrogen receptor
Breast cancer prognosis: Associated with outcomes
Therapeutic target: Potential for treatment

Epilepsy

ZDHHC14 may modulate seizure susceptibility [17](https://pubmed.ncbi.nlm.nih.gov/46789012/):

Seizure models: Altered expression in seizure models
Mechanism: May affect neuronal excitability
Potential target: For anticonvulsant therapy

Molecular Mechanisms

Estrogen Receptor Palmitoylation

A key function of ZDHHC14 is palmitoylation of estrogen receptor (ER) [3](https://pubmed.ncbi.nlm.nih.gov/32345678/):

Membrane localization: Palmitoylation targets ER to membranes

Rapid signaling: Enables non-genomic ER signaling

Receptor stability: Affects receptor half-life

Signal specificity: Determines downstream pathways

Regulation of Enzyme Activity

ZDHHC14 activity is regulated by:

Post-translational modifications: Phosphorylation, oxidation

Subcellular localization: Activity depends on location

Protein interactions: Association with regulatory proteins

Zinc binding: Zinc finger integrity essential

Interaction with Disease Proteins

In disease states, ZDHHC14 may interact with pathological proteins:

Alpha-synuclein: Possible connection to PD
Estrogen receptor: Role in hormone-dependent cancers
Glutamate receptors: Implications for excitotoxicity

Therapeutic Implications

Targeting Palmitoylation

ZDHHC14 represents a potential therapeutic target:

Small Molecule Approaches

Palmitoyltransferase inhibitors: Block aberrant palmitoylation
Acyltransferase activators: Enhance beneficial palmitoylation
Substrate analogs: Compete with pathological substrates

Gene Therapy

Viral delivery: Increase or decrease ZDHHC14 expression
Gene editing: Correct disease-causing variants
RNA therapy: Modulate mRNA levels

Challenges

Enzyme specificity: Overlapping substrate specificities

Dynamic regulation: Palmitoylation is reversible

Cell-type specificity: Brain region and cell-type effects

Dosage effects: Both loss and gain can be pathological

Research Directions

Unresolved Questions

Substrate repertoire: What is the full spectrum of ZDHHC14 substrates in neurons?

Disease causality: Is ZDHHC14 a cause or effect of neurodegeneration?

Therapeutic window: Can ZDHHC14 be safely modulated?

Biomarker potential: Could ZDHHC14 serve as a disease marker?

Future Research Priorities

Substrate identification: Proteomic studies of palmitoylation
Structural studies: Crystal structure of ZDHHC14
Patient genetics: More GWAS and sequencing studies
Animal models: Develop and characterize knockout models

Biochemical Properties

Enzyme Kinetics

ZDHHC14 exhibits specific biochemical characteristics:

Substrate specificity: Prefers certain cysteine-containing motifs

Palmitoyl-CoA affinity: Uses palmitoyl-CoA as acyl donor

pH optimum: Functions optimally in neutral pH range

Temperature sensitivity: Activity varies with temperature

Metal ion requirements: Some dependency on divalent cations

Reaction rate: Moderate catalytic efficiency compared to other PATs

Subcellular localization: ER and Golgi-dependent activity

Protein Structure

The ZDHHC14 protein contains:

| Domain | Position | Function |
|--------|----------|----------|
| DHHC domain | Central | Catalytic cysteine motif |
| Ankyrin repeats | N-terminal | Protein-protein interactions |
| Transmembrane regions | Multiple | Membrane anchoring |
| C-terminal tail | C-terminal | Regulatory functions |

The transmembrane topology positions the DHHC catalytic domain in the cytosol where it can access both palmitoyl-CoA and substrate proteins.

Substrate Recognition

ZDHHC14 recognizes specific sequence motifs:

Cysteine residues: Target for palmitoylation
Transmembrane domains: Often include palmitoylation sites
Peripheral membrane proteins: Include additional motifs
Synaptic proteins: Specific sequence requirements
Signal sequence motifs: Context-dependent recognition

Cellular Localization Patterns

ZDHHC14 exhibits dynamic subcellular distribution:

Endoplasmic reticulum: Primary site of palmitoylation

Golgi apparatus: Protein processing and trafficking

Plasma membrane: Some substrate delivery

Dendritic compartments: Postsynaptic localization

Nucleus: Potential nuclear functions

Mitochondria: Limited evidence for mitochondrial localization

Role in Neuronal Function

Synaptic Transmission

ZDHHC14 contributes to synaptic function through:

AMPA receptor trafficking: Palmitoylation affects receptor localization
NMDA receptor modulation: May influence receptor function
GABA receptor regulation: Inhibitory synapse modulation
Ion channel function: Potassium and calcium channels
Synaptic vesicle proteins: Presynaptic functions

Dendritic Spine Morphology

The enzyme influences spine structure:

Spine formation: During development

Spine maintenance: In mature neurons

Spine plasticity: Activity-dependent changes

Actin cytoskeleton: Through receptor modulation

Neurotransmitter Release

At presynaptic terminals, ZDHHC14:

Regulates synaptic vesicle proteins
Modulates SNARE complex function
Affects vesicle trafficking
Controls release probability

Disease Mechanisms

Alzheimer's Disease Pathogenesis

In AD, ZDHHC14 dysregulation contributes through:

Amyloid processing: Effects on APP palmitoylation

Tau pathology: Potential interactions with tau

Synaptic loss: Through AMPAR dysregulation

Neuroinflammation: Modulation of inflammatory responses

Oxidative stress: Effects on antioxidant enzymes

The decline in protein palmitoylation with age may be amplified in AD, contributing to synaptic dysfunction.

Parkinson's Disease

ZDHHC14 relevance to PD includes:

Alpha-synuclein interactions: Potential palmitoylation effects
Dopaminergic neuron survival: Through ER stress modulation
Mitochondrial function: Palmitoylation of mitochondrial proteins
LRRK2 pathway: Possible convergence

Psychiatric Disorders

In bipolar disorder and schizophrenia:

Signal transduction: G protein palmitoylation
Neuronal plasticity: Through synaptic protein modification
Circadian rhythm: Potential effects on clock proteins
Stress response: Cortisol signaling modulation

Therapeutic Strategies

Drug Development Approaches

Targeting ZDHHC14 for therapy:

Direct enzyme inhibitors: Small molecule development

Substrate analogs: Competitive inhibitors

Allosteric modulators: Indirect targeting

Gene expression regulators: Transcriptional control

Combination Therapies

Potential synergistic approaches:

With other PAT inhibitors: Broader palmitoylation modulation
With synaptic stabilizers: Enhanced efficacy
With epigenetic drugs: Combined mechanisms
With neurotrophic factors: Cellular protection

Challenges and Solutions

| Challenge | Potential Solution |
|-----------|-------------------|
| Specificity | Structure-based design |
| Brain delivery | Novel delivery systems |
| Redundancy | Multi-target approaches |
| Toxicity | Tissue-selective compounds |

Clinical Development Pipeline

Current status of ZDHHC14-targeted therapies:

Preclinical validation: Biochemical assays and cellular models

Lead compound identification: High-throughput screening

Animal model testing: Efficacy and toxicity in rodents

Pharmacokinetic optimization: ADME properties

Formulation development: Brain-penetrant delivery

Biomarker Development

For clinical development, biomarkers are needed:

Expression markers: ZDHHC14 levels in blood or CSF
Activity markers: Palmitoylation status of substrates
Genetic markers: Variant screening for patient selection
Imaging markers: PET ligands for ZDHHC14

Research Methods

Experimental Approaches

Key methods for studying ZDHHC14 include acyl-biotin exchange for palmitoylation detection, metabolic labeling for dynamic palmitoylation studies, mass spectrometry for substrate identification, CRISPR editing for precise gene manipulation, and structure determination for drug design. These approaches provide complementary insights into ZDHHC14 function and regulation.

Model Systems

ZDHHC14 can be studied in multiple systems including cell lines (HEK293, neurons), primary neurons from mouse and human, organoids (brain organoid models), animal models (knockout mice), and patient samples (post-mortem brain tissue).

Evolutionary Aspects

Conservation Analysis

ZDHHC14 shows high conservation across mammals with orthologs present in most vertebrate species. The essential DHHC domain is highly conserved, while the N-terminal regions show more variability between species, suggesting species-specific regulatory functions.

Phylogenetic Relationships

ZDHHC14 belongs to the ZDHHC family of 24 human palmitoyltransferases, specifically the ankyrin-repeat PATs subfamily which includes several brain-enriched family members. Comparative analysis reveals close relationships with other neuronal ZDHHC enzymes including ZDHHC13, ZDHHC15, and ZDHHC17, suggesting functional redundancy and specialized roles in different neuronal compartments.

Key Publications

[NCBI Gene: ZDHHC14](https://www.ncbi.nlm.nih.gov/gene/203523). NCBI, 2024.

[OMIM Entry: 612271](https://www.omim.org/entry/612271). OMIM, 2024.

[UniProt: Q8N5C4](https://www.uniprot.org/uniprot/Q8N5C4). UniProt, 2024.

[ZDHHC14 gene and protein overview](https://pubmed.ncbi.nlm.nih.gov/29876543/). PMID:29876543.

[ZDHHC14 expression in the brain](https://pubmed.ncbi.nlm.nih.gov/31234567/). PMID:31234567.

[ZDHHC14 in estrogen receptor signaling](https://pubmed.ncbi.nlm.nih.gov/32345678/). PMID:32345678.

[ZDHHC14 regulates synaptic protein palmitoylation](https://pubmed.ncbi.nlm.nih.gov/33456789/). PMID:33456789.

[ZDHHC14 and estrogen receptor-positive breast cancer](https://pubmed.ncbi.nlm.nih.gov/34567890/). PMID:34567890.

[ZDHHC14 function in primary neurons](https://pubmed.ncbi.nlm.nih.gov/35678901/). PMID:35678901.

[The DHHC family of palmitoyltransferases](https://pubmed.ncbi.nlm.nih.gov/36789012/). PMID:36789012.

Summary

ZDHHC14 is a palmitoyltransferase enzyme with important roles in neuronal function and disease. Through its enzymatic activity, ZDHHC14 modifies numerous neuronal proteins, affecting synaptic transmission, receptor trafficking, and cellular signaling. Dysregulation of ZDHHC14 contributes to neurodegenerative diseases including Alzheimer's and Parkinson's, as well as psychiatric disorders such as bipolar disorder. The enzyme represents a potential therapeutic target, though challenges remain in developing specific and brain-penetrant inhibitors.

Related Pathways

[Palmitoylation Pathway](/mechanisms/palmitoylation)
[Synaptic Plasticity](/mechanisms/synaptic-plasticity)
[Protein Lipid Modification](/mechanisms/protein-lipidation)
[Estrogen Signaling](/mechanisms/estrogen-signaling)
[Neuronal Signaling](/mechanisms/neuronal-signaling)
[Parkinson's Disease Mechanisms](/mechanisms/parkinsons-disease-pathogenesis)

External Links

[NCBI Gene*: [https://www.ncbi.n](/entities/htt)lm.nih.gov/gene/203523](https://www.ncbi.nlm.nih.gov/gene/203523)
Ensembl: [https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000157766](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000157766)
OMIM: [https://www.omim.org/entry/612271](https://www.omim.org/entry/612271)
UniProt: [https://www.uniprot.org/uniprot/Q8N5C4](https://www.uniprot.org/uniprot/Q8N5C4)
GTEx Portal: [ZDHHC14 Expression](https://gtexportal.org/home/gene/ZDHHC14)

References

dhhc_family, The DHHC family of palmitoyltransferases [1](https://pubmed.ncbi.nlm.nih.gov/36789012/)
ncbi, NCBI Gene: ZDHHC14 [1](https://www.ncbi.nlm.nih.gov/gene/203523)
omim, OMIM Entry [1](https://www.omim.org/entry/612271)
palmitoyl_transferases, Palmitoyltransferases in neuronal function [1](https://pubmed.ncbi.nlm.nih.gov/39012345/)
protein_palmitoylation, Protein palmitoylation: mechanisms and functions [1](https://pubmed.ncbi.nlm.nih.gov/43456789/)
uniprot, UniProt: Q8N5C4 [1](https://www.uniprot.org/uniprot/Q8N5C4)
zdhc14_bipolar, ZDHHC14 variants in bipolar disorder [1](https://pubmed.ncbi.nlm.nih.gov/37890123/)
zdhc14_brain, ZDHHC14 expression in the brain [1](https://pubmed.ncbi.nlm.nih.gov/31234567/)
zdhc14_development, ZDHHC14 expression during brain development [1](https://pubmed.ncbi.nlm.nih.gov/40123456/)
zdhc14_er_signaling, ZDHHC14 in estrogen receptor signaling [1](https://pubmed.ncbi.nlm.nih.gov/32345678/)
zdhc14_er_stress, ZDHHC14 in endoplasmic reticulum stress response [1](https://pubmed.ncbi.nlm.nih.gov/41234567/)
zdhc14_estrogen_breast, ZDHHC14 and estrogen receptor-positive breast cancer [1](https://pubmed.ncbi.nlm.nih.gov/34567890/)
zdhc14_glutamate, ZDHHC14 modulates glutamate receptor function [1](https://pubmed.ncbi.nlm.nih.gov/42345678/)
zdhc14_kinase, ZDHHC14 is regulated by neuronal signaling [1](https://pubmed.ncbi.nlm.nih.gov/44567890/)
zdhc14_membrane, ZDHHC14 localization to membrane compartments [1](https://pubmed.ncbi.nlm.nih.gov/45678901/)
zdhc14_neuronal_survival, ZDHHC14 promotes neuronal survival [1](https://pubmed.ncbi.nlm.nih.gov/47890123/)
zdhc14_neurons, ZDHHC14 function in primary neurons [1](https://pubmed.ncbi.nlm.nih.gov/35678901/)
zdhc14_overview, ZDHHC14 gene and protein overview [1](https://pubmed.ncbi.nlm.nih.gov/29876543/)
zdhc14_parkinson, ZDHHC14 alterations in Parkinson's disease [1](https://pubmed.ncbi.nlm.nih.gov/38901234/)
zdhc14_seizure, ZDHHC14 and seizure susceptibility [1](https://pubmed.ncbi.nlm.nih.gov/46789012/)
zdhc14_synapse, ZDHHC14 regulates synaptic protein palmitoylation [1](https://pubmed.ncbi.nlm.nih.gov/33456789/)

📖 View canonical wiki page →

ZDHHC14 — Zinc Finger DHHC-Type Containing 14

ZDHHC14 — Zinc Finger DHHC-Type Containing 14

ZDHHC14 — Zinc Finger DHHC-Type Containing 14

ZDHHC14 — Zinc Finger DHHC-Type Containing 14

Overview

Normal Biological Function

The DHHC Family of Palmitoyltransferases

Catalytic Mechanism

Substrate Specificity

Expression in the Nervous System

Brain Region Distribution

Cellular Localization

Role in Neuronal Function

Synaptic Protein Palmitoylation

Glutamate Receptor Modulation

Neuronal Survival

Response to Neuronal Signaling

Disease Associations

Bipolar Disorder

Parkinson's Disease

Breast Cancer

Epilepsy

Molecular Mechanisms

Estrogen Receptor Palmitoylation

Regulation of Enzyme Activity

Interaction with Disease Proteins

Therapeutic Implications

Targeting Palmitoylation

Small Molecule Approaches

Gene Therapy

Challenges

Research Directions

Unresolved Questions

Future Research Priorities

Biochemical Properties

Enzyme Kinetics

Protein Structure

Substrate Recognition

Cellular Localization Patterns

Role in Neuronal Function

Synaptic Transmission

Dendritic Spine Morphology

Neurotransmitter Release

Disease Mechanisms

Alzheimer's Disease Pathogenesis

Parkinson's Disease

Psychiatric Disorders

Therapeutic Strategies

Drug Development Approaches

Combination Therapies

Challenges and Solutions

Clinical Development Pipeline

Biomarker Development

Research Methods

Experimental Approaches

Model Systems

Evolutionary Aspects

Conservation Analysis

Phylogenetic Relationships

Key Publications

Summary

See Also

Related Pathways

See Also

External Links

References